Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections | MicrobiomeTrials← Back to trialsNCT07704333
Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07-09Est. Completion: 2029-06-30
Enrollment target: 98 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States